Louise Wright

I am Research Coordinator for the SINAPPS Research Group  which is led by Professor Belinda Lennox.  The SINAPPS2 trial is being conducted to test if immunotherapy is an effective treatment for people with psychosis and presence of anti-neuronal membrane antibodies. It is a randomised phase II double-blinded placebo-controlled trial of intravenous immunoglobulin and rituximab in patients with antibody-mediated psychosis. Antibody positive patients with psychosis are identified in the PPiP2 study which is conducted in more than 40 mental health NHS trusts across the UK.  I am assisting both PPiP2 and SINAPPS2 from our team base in Oxford. My main responsibility is to ensure our office and lab based research activities are running smoothly.

I have worked within the NHS for a number of years in roles such as Diabetic Eye Screener, Secretary/PA in Endocrinology and Haematology and Data Manager in Late Phase Haematology Research.  Within Mental Health, as PA for a Consultant Psychiatrist, PA for Medical Director and Associate Medical Director of the trust and Communications Assistant in the Executive Office. 

Further information on the trial can be found at: http://www.sinapps.org.uk/sinapps2/4593872410